Anavex Life Sciences Corp (AVXL)

[nidan7500]

The manager is being paid to create revenues"--when (not if) our SP soars

At this point we are paying staff to generate and implement a strategic and tactical plan which will optimize and leverage the AVXL science. As pre revenue Biotec and talks on revenue are future what-if's. That is OK but it's cart before horse discussion right now.

Is the strategic plan the right one based on facts and opportunities realistically available now-near future? Have the plans been realistically scaled and put on doable-measurable timelines? Are plans being executed (more or less as scheduled), remember, this CNS disease science has decades of very high failure rates so there is no HOW TO DO BIOTEC pamphlet laying around.

These and other related-time sensitive metrics make sense as an AVXL baseline discussion, IMO. Kind of early to judge by traditional revenue metric.

So FAR (admit I was not sure about the RSD choice) but now see it as a good starting place. We are now CAVU-ceiling and visibility unlimited, IMO. Expecting bits of news soon , some of which we may not see as key but I am not sure I would know a strong bit when/if I saw one. Stand by.